NAPLES, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG), a leading entity in the music industry, is excited to announce the acquisition of the royalty rights to “Thank God I Got It” by the renowned artist Desiigner. This acquisition underscores Music Licensing, Inc.’s commitment to diversifying its portfolio with high-quality, revenue-generating […]
Music Licensing, Inc. (OTC: SONG) Announces Acquisition of Royalty Rights to “Thank God I Got It” by Desiigner, Bolstering Its Diverse and Star-Studded Portfolio
NAPLES, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG), a leading entity in the music industry, is excited to announce the acquisition of the royalty rights to “Thank God I Got It” by the renowned artist Desiigner. This acquisition underscores Music Licensing, Inc.’s commitment to diversifying its portfolio with high-quality, revenue-generating […]
شركة Music Licensing, Inc. (OTC: SONG) تعلن استحواذها على حقوق ملكية أغنية “Thank God I Got It” للفنان Desiigner، مما يعزز محفظتها المتنوعة والزاخرة بالنجوم
نيبلز، فلوريدا،, Sept. 03, 2024 (GLOBE NEWSWIRE) — يَسُر شركة Music Licensing, Inc. (OTC: SONG)، وهي كيان رائد في صناعة الموسيقى، أن تعلن عن استحواذها على حقوق ملكية أغنية “Thank God I Got It” للفنان الشهير Desiigner. ويؤكد هذا الاستحواذ على التزام شركة Music Licensing, Inc. بتنويع محفظتها بأصول عالية الجودة ومُدرّة للإيرادات. تُضَاف عملية […]
شركة Music Licensing, Inc. (OTC: SONG) تعلن استحواذها على حقوق ملكية أغنية “Thank God I Got It” للفنان Desiigner، مما يعزز محفظتها المتنوعة والزاخرة بالنجوم
نيبلز، فلوريدا،, Sept. 03, 2024 (GLOBE NEWSWIRE) — يَسُر شركة Music Licensing, Inc. (OTC: SONG)، وهي كيان رائد في صناعة الموسيقى، أن تعلن عن استحواذها على حقوق ملكية أغنية “Thank God I Got It” للفنان الشهير Desiigner. ويؤكد هذا الاستحواذ على التزام شركة Music Licensing, Inc. بتنويع محفظتها بأصول عالية الجودة ومُدرّة للإيرادات. تُضَاف عملية […]
Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to […]
Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to […]